Latest Articles

Publication Date
All News Scientific
Key Opinion Leader (KOL) Panel to Discuss Acrivon’s ACR-368 Endometrial Cancer (EC) Trial during the 2026 European Society of Gynecological Oncology (ESGO) Congress - Yahoo Finance

Key Opinion Leader (KOL) Panel to Discuss Acrivon’s ACR-368 Endometrial Cancer (EC) Trial during the 2026 European Society of Gynecological Oncology (ESGO) Congress Yahoo Finance

Published: Feb. 23, 2026, 1 p.m.
Read Full Article
From bench to bedside: unlocking the anti-inflammatory, antioxidant, and anticancer promise of curcumin in gynecology.

Curcumin, a bioactive polyphenol derived from turmeric (Curcuma longa), has garnered substantial attention for its potent anti-inflammatory, antioxidant, and antineoplastic properties. This review explores the therapeutic potential of curcumin in …

Published: Feb. 20, 2026, midnight
Read Full Article
curcumin endometriosis gynecological cancer menopause polycystic ovary syndrome polyphenols premenstrual syndrome
Sensei finds Faeth | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline

Sensei finds Faeth | ApexOnco - Clinical Trials news and analysis Oncology Pipeline

Published: Feb. 19, 2026, 3:47 p.m.
Read Full Article
Advancing Precision: The Vital Role of Biomarker Testing in Endometrial Cancer - Targeted Oncology

Advancing Precision: The Vital Role of Biomarker Testing in Endometrial Cancer Targeted Oncology

Published: Feb. 6, 2026, 10:05 p.m.
Read Full Article
How Does Rina-S Work in Patients With Pretreated Endometrial Cancer? - Oncology Nursing News

How Does Rina-S Work in Patients With Pretreated Endometrial Cancer? Oncology Nursing News

Published: Feb. 5, 2026, 5:03 p.m.
Read Full Article
TIGIT Inhibitors Market Poised for Strong Growth Through 2034, Driven by Expanding Immuno-Oncology Pipeline | DelveInsight - The Malaysian Reserve

TIGIT Inhibitors Market Poised for Strong Growth Through 2034, Driven by Expanding Immuno-Oncology Pipeline | DelveInsight The Malaysian Reserve

Published: Feb. 2, 2026, 11:43 p.m.
Read Full Article
Evaluating the Molecular Landscape in Endometrial Cancer to Optimize Treatment - Targeted Oncology

Evaluating the Molecular Landscape in Endometrial Cancer to Optimize Treatment Targeted Oncology

Published: Jan. 28, 2026, 10:02 p.m.
Read Full Article
Acrivon Therapeutics Announces Late-Breaking Oral Presentation at Upcoming European Society of Gynecological Oncology (ESGO) Annual International Congress - The Manila Times

Acrivon Therapeutics Announces Late-Breaking Oral Presentation at Upcoming European Society of Gynecological Oncology (ESGO) Annual International Congress The Manila Times

Published: Jan. 23, 2026, 1:20 p.m.
Read Full Article
Acrivon Therapeutics Announces Late-Breaking Oral Presentation at Upcoming European Society of Gynecological Oncology (ESGO) Annual International Congress - manilatimes.net

Acrivon Therapeutics Announces Late-Breaking Oral Presentation at Upcoming European Society of Gynecological Oncology (ESGO) Annual International Congress manilatimes.net

Published: Jan. 23, 2026, 1:20 p.m.
Read Full Article
Fruquintinib/Sintilimab Yields Efficacy, Safety in Advanced pMMR Endometrial Cancer - Targeted Oncology

Fruquintinib/Sintilimab Yields Efficacy, Safety in Advanced pMMR Endometrial Cancer Targeted Oncology

Published: Jan. 22, 2026, 4:02 p.m.
Read Full Article
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!